Table 1. Characteristics of patients with SARS-CoV-2 infection (confirmed with both PCR and CT) and controls.
Patients | Controls | p-value | |
---|---|---|---|
n | 100 | 100 | |
Age | 65 [24] | 60 [31] | 0.14 |
Sex (M:F) | 65:35 | 45:55 | 0.005 |
Clinical characteristics | |||
Cough | 79 | 66 | 0.04 |
Fever | 90 | 63 | <0.001 |
Temperature at ER | 37.7 [1.4] | 37 [0.7] | 0.28 |
Shortness of breath | 70 | 69 | 0.88 |
Saturation | 95% [6] | 96% [4] | 0.03 |
Diarrhea | 22 | 14 | 0.14 |
Myalgia | 34 | 17 | 0.006 |
Headaches | 16 | 18 | 0.71 |
Anosmia | 11 | 5 | 0.12 |
Agueusia | 14 | 4 | 0.01 |
Time from onset | 6d [5] | 5d [5] | 0.12 |
Comorbidities | |||
Comorbidities | 61 | 70 | 0.18 |
Diabetes | 19 | 19 | 1 |
Hypertension | 32 | 21 | 0.08 |
Renal failure | 7 | 6 | 0.77 |
Pulmonary disease¤ | 17 | 43 | <0.001 |
Immunodeficiency/ autoimmune disease | 13 | 23 | 0.07 |
Including: HIV | 2 | 5 | 0.25 |
Treatments | |||
Steroids | 4 | 7 | 0.35 |
Chemotherapy | 2 | 3 | 0.65 |
Blood tests | |||
Hemoglobin (g/dL) | 13.70 [2.50] | 13.20 [2.10] | 0.31 |
Lymphocytes (G/L) | 0.87 [0.48] | 1.96. [1.18] | <0.001 |
Neutrophils (G/L) | 4.29 [3.06] | 6.47 [4.55] | <0.001 |
Eosinophils (G/L) | 0.00 [0.01] | 0.10 [0.19] | <0.001 |
Basophils (G/L) | 0.01 [0.03] | 0.04 [0.01] | <0.001 |
Monocytes (G/L) | 0.44 [0.33] | 0.70 [0.46] | <0.001 |
Platelets (G/L) | 195.00 [91.75] | 253.00 97.25] | <0.001 |
Sodium (mmol/L) | 136.00 [5.00] | 137.00 [4.25] | 0.008 |
Potassium (mmol/L) | 4.0 [0.50] | 4.00 [0.40] | 0.97 |
Chloride (mmol/L) | 97.00 [4.00] | 98.50 [5.00] | 0.001 |
Bicarbonate (mmol/L) | 24.00 [3.83] | 24.00 [4.03] | 0.82 |
Total protein (g/L) | 71.80 [6.80] | 74.00 [7.00] | 0.07 |
Creatinine (μmol/L) | 82.00 [33.50] | 78.00 [31.50] | 0.39 |
CRP (mg/L) | 62.2 [78.20] | 11.1 [67.40] | <0.001 |
¤Pulmonary disease: asthma, COPD or restrictive syndrome; Results are presented as median [interquartile range]; G/L = 109/ Liter.